Filter by
Filter by
Results
Filter by
Content type
Key content topics
Key audience
Top cancer treatments
Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer
08/02/2018
/
Publications
/
Hypofractionation
Quality of life
A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...